285 related articles for article (PubMed ID: 20040909)
21. Current and future therapeutic approach for Waldenström's macroglobulinemia.
Souchet-Cömpain L; Choquet S; Leblond V; Nguyen S
Immunotherapy; 2014; 6(3):333-48. PubMed ID: 24762077
[TBL] [Abstract][Full Text] [Related]
22. Amyloidosis and Waldenström's macroglobulinemia.
Gertz MA; Merlini G; Treon SP
Hematology Am Soc Hematol Educ Program; 2004; ():257-82. PubMed ID: 15561687
[TBL] [Abstract][Full Text] [Related]
23. How we treat Waldenström's macroglobulinemia.
Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
[TBL] [Abstract][Full Text] [Related]
24. How I treat Waldenström macroglobulinemia.
Treon SP
Blood; 2015 Aug; 126(6):721-32. PubMed ID: 26002963
[TBL] [Abstract][Full Text] [Related]
25. Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.
Anderson KC; Alsina M; Bensinger W; Biermann JS; Cohen AD; Devine S; Djulbegovic B; Faber EA; Gasparetto C; Hernandez-Ilizaliturri F; Huff CA; Kassim A; Krishnan AY; Medeiros BC; Meredith R; Raje N; Schriber J; Singhal S; Somlo G; Stockerl-Goldstein K; Treon SP; Tricot G; Weber DM; Yahalom J; Yunus F; Kumar R; Shead DA;
J Natl Compr Canc Netw; 2012 Oct; 10(10):1211-9. PubMed ID: 23054875
[TBL] [Abstract][Full Text] [Related]
26. Waldenström's macroglobulinemia.
Dimopoulos MA; Anagnostopoulos A
Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
[TBL] [Abstract][Full Text] [Related]
27. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Dogliotti I; Jiménez C; Varettoni M; Talaulikar D; Bagratuni T; Ferrante M; Pérez J; Drandi D; Puig N; Gilestro M; García-Álvarez M; Owen R; Jurczak W; Tedeschi A; Leblond V; Kastritis E; Kersten MJ; D'Sa S; Kaščák M; Willenbacher W; Roccaro AM; Poulain S; Morel P; Kyriakou C; Fend F; Vos JMI; Dimopoulos MA; Buske C; Ferrero S; García-Sanz R
Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884
[TBL] [Abstract][Full Text] [Related]
28. Managing complications secondary to Waldenström's macroglobulinemia.
Pessach I; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2021 Jul; 14(7):621-632. PubMed ID: 34170207
[No Abstract] [Full Text] [Related]
29. Waldenström macroglobulinemia.
Ghobrial IM; Witzig TE
Curr Treat Options Oncol; 2004 Jun; 5(3):239-47. PubMed ID: 15115652
[TBL] [Abstract][Full Text] [Related]
30. High-Dose Therapy and Hematopoietic Stem Cell Transplantation in Waldenström Macroglobulinemia.
Kyriakou C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):865-874. PubMed ID: 30190024
[TBL] [Abstract][Full Text] [Related]
31. Advances in the treatment of Waldenström's macroglobulinemia.
Johnson SA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):329-34. PubMed ID: 16503850
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of Waldenstrom's macroglobulinemia.
Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
[TBL] [Abstract][Full Text] [Related]
33. Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment.
Kapoor P; Ansell SM; Braggio E
Cancer Treat Res; 2016; 169():321-361. PubMed ID: 27696269
[TBL] [Abstract][Full Text] [Related]
34. Waldenstrom's macroglobulinemia.
Singhal N; Bapsy PP; Babu KG; Sahoo TP
J Assoc Physicians India; 2004 Dec; 52():981-5. PubMed ID: 15884458
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathogenesis of Waldenstrom's macroglobulinemia.
Braggio E; Philipsborn C; Novak A; Hodge L; Ansell S; Fonseca R
Haematologica; 2012 Sep; 97(9):1281-90. PubMed ID: 22773606
[TBL] [Abstract][Full Text] [Related]
36. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
Berentsen S
Clin Lymphoma Myeloma; 2009 Mar; 9(1):110-2. PubMed ID: 19362990
[TBL] [Abstract][Full Text] [Related]
37. Waldenström macroglobulinemia: from biology to treatment.
Sahin I; Leblebjian H; Treon SP; Ghobrial IM
Expert Rev Hematol; 2014 Feb; 7(1):157-68. PubMed ID: 24405328
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
Kyle RA; Ansell SM; Kapoor P
Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
[TBL] [Abstract][Full Text] [Related]
39. Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management.
Gertz MA
Am J Hematol; 2019 Feb; 94(2):266-276. PubMed ID: 30328142
[TBL] [Abstract][Full Text] [Related]
40. Waldenström's macroglobulinemia.
Dimopoulos MA; Galani E; Matsouka C
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1351-66. PubMed ID: 10626154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
